Cite
HARVARD Citation
Darpo, B. et al. (n.d.). Cardiac Safety of Omadacycline in the IV/oral Phase 3 Acute Bacterial Skin and Skin Structure Infection (ABSSSI) and in the IV/oral Phase 3 Community-acquired Bacterial Pneumonia (CABP) Studies. Open forum infectious diseases. pp. S544-S545. [Online].